Phase 3 study of disitamab vedotin with pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2 (DV-001; trial in progress)

Saved in:
Bibliographic Details
Published in:European urology 2024-03, Vol.85, p.S1721
Main Authors: Powles, T., Grande, E., Van Der Heijden, M., Necchi, A., Iyer, G., Drakaki, A., Loriot, Y., Sokolowski, K., Zhang, W., Galsky, M.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0302-2838
DOI:10.1016/S0302-2838(24)01317-4